CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (41,014)	$ (24,145)
Adjustments to reconcile net loss to net cash used for operating activities:
Non-cash royalty revenue related to sale of future royalties	(2,157)	(2,364)
Non-cash interest expense on liability related to sale of future royalties and convertible senior notes	853	1,249
Depreciation and amortization	448	473
Stock and deferred share unit compensation	7,067	4,407
Change in operating assets and liabilities:
Accounts receivable	(14,746)	3,277
Unbilled receivable	282	(1,298)
Inventory	(709)
Prepaid and other current assets	50	(1,485)
Operating lease right-of-use assets	604	504
Other assets	(485)	39
Accounts payable	(12,975)	(2,308)
Accrued compensation	670	(2,061)
Other accrued liabilities	(7,913)	5,023
Deferred revenue	(2,712)	(21,957)
Operating lease liability	(982)	(756)
Net cash used for operating activities	(73,719)	(41,402)
Cash flows from investing activities:
Purchases of property and equipment	(209)	(307)
Net cash used for investing activities	(209)	(307)
Cash flows from financing activities:
Proceeds from issuance of common stock under stock plans	39	620
Net cash provided by financing activities	39	620
Net change in cash and cash equivalents	(73,889)	(41,089)
Cash and cash equivalents, beginning of period		275,138	$ 478,750
Cash and cash equivalents, end of period	$ 201,249	$ 437,661